Navigation Links
InterMune Reports First Quarter 2013 Financial Results and Business Highlights
Date:4/24/2013

sbriet in Spain and the Netherlands in the fourth quarter of this year.

First Quarter 2013 Financial Results (Unaudited)
InterMune reported total Esbriet revenue in the first quarter of 2013 of $10.5 million, compared with $4.9 million in the first quarter of 2012, an increase of 114 percent.  Sequentially, Esbriet revenue in the first quarter of 2013 increased 28 percent from $8.2 million in the fourth quarter of 2012. 

Research and development (R&D) expenses in the first quarter of 2013 were $25.9 million compared with $23.2 million in the first quarter of 2012, an increase of 12 percent.  Higher R&D expenses reflect increased expenses primarily due to conduct of the ASCEND trial, which enrollment was completed on January 9, 2013.Selling, general and administrative (SG&A) expenses were $30.0 million in the first quarter of 2013, compared with $26.3 million in the same period a year earlier, an increase of 14 percent.  The increased spending for the three-month period in 2013 compared with the same period in 2012 is attributed to the continued development of InterMune's commercial infrastructure and investments in the pre-launch and launches of Esbriet in Europe and Canada.InterMune reported a net loss for the first quarter of 2013 of $49.9 million, or $0.64 per share, compared with a net loss of $46.6 million, or $0.72 per share, in the first quarter of 2012.  Per share amounts included gains from the role of Actimmune® (interferon gamma-1b) in discontinued operations of $0.01 per share and $0.03 per share in the first quarters of 2013 and 2012, respectively.As a result of the June 19, 2012 divestiture of Actimmune, historical Actimmune revenue, cost of goods sold, operating costs, and tax impact are reported in discontinued operations in this and future financial statements and therefore do not appear in the comparisons above regarding on-going operations.

As of March 31, 2013, Int
'/>"/>

SOURCE InterMune, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. InterMune to Report Unaudited Fourth Quarter Esbriet® Revenue and Business Update on January 5
2. InterMune to Present at J. P. Morgan Healthcare Conference
3. InterMune to Release Fourth Quarter and Full Year Financial Results on February 9
4. InterMune To Present At JMP Securities Healthcare Conference
5. InterMune To Release Third Quarter Financial Results On November 7
6. InterMune Reports Third Quarter 2012 Financial Results And Business Highlights
7. InterMune Reports Fourth Quarter And Full Year 2012 Financial Results And Business Highlights
8. InterMune To Release First Quarter Financial Results On April 24
9. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
10. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
11. Interleukin Genetics Reports Third Quarter 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... OncoTAb, Inc., a University of ... that Pinku Mukherjee, Ph.D. has received the O. ... highest faculty honor. Mukherjee received the award, which recognizes ... innovative research and development of cancer diagnostics and treatments. ... moment in my scientific career,” said Mukherjee, OncoTAb Co-founder ...
(Date:5/1/2015)... TORONTO , May 1, 2015 /CNW/ - Softchoice, a leading ... that it is the proud recipient of two Cisco® Partner ... Services Partner of the Year and Security Partner of the ... partner conference taking place this week in Montreal ... not one, but two Cisco partner awards at this year,s ...
(Date:5/1/2015)... 2015 Albany Molecular Research Inc. (NASDAQ: ... , AMRI,s President and Chief Executive Officer, will present ... Care Conference on Wednesday, May 13, 2015 at 4:20 ... the presentation can be accessed at AMRI,s Investor Relations ... webcast will be archived for 90 days following the ...
(Date:4/30/2015)... Carolina (PRWEB) May 01, 2015 Spirax ... services, is extremely proud to announce that for the ... named as a winner of a Queen’s Award for ... for the design and manufacture of a unique flowmeter. ... the revolutionary alternative to traditional steam flow measurement. ...
Breaking Biology Technology:OncoTAb CSO Awarded the University of North Carolina’s O. Max Gardner Award 2Softchoice recognized with two Country Awards at Cisco Partner Summit 2015 2AMRI to Present at the Bank of America Merrill Lynch 2015 Health Care Conference 2Spirax Sarco Receives a Queen’s Award for Innovation 2Spirax Sarco Receives a Queen’s Award for Innovation 3
... University chemist Krzysztof Matyjaszewski are using electricity from a ... widely used method of creating industrial plastics. The environmentally ... Science , represents a breakthrough in the level ... which will allow for the creation of even more ...
... Conn.Fuel cells have been touted as a cleaner solution ... from cars to computers. But one reason ... of endurance. Over time, the catalysts used even in ... reaction that converts fuel into electricity. In addition, current ...
... launched the 2011 Bio NC® Hotbed Campaign this ... and across North Carolina. (Logo: http://www.newscom.com/cgi-bin/prnh/20040907/CLTU006LOGO) ... campaign participant,s logo is added to an electronic and printed ... industry events or career fairs. "We have ...
Cached Biology Technology:Carnegie Mellon researchers electrify polymerization 2Carnegie Mellon researchers electrify polymerization 3Novel nanowires boost fuel cell efficiency 2BioSpace Highlights North Carolina's Life Science Regions 2
(Date:4/13/2015)... April 13, 2015 According ... "Global Biometrics Market Forecast & Opportunities, 2020", the global ... of around 14% till 2020. The biometrics market ... scale implementation and review of biometric management systems. ... new products with greater efficiency, are resulting in ...
(Date:4/9/2015)... JOSE, Calif. , April 9, 2015 ... human interface solutions, announced today that it will report ... on Thursday, April 23, 2015, after the close of ... for analysts and investors at 2:00 p.m. PT (5:00 ...   To participate on the live call, ...
(Date:4/2/2015)... In the current eight ... the strongest competitors, showing outstanding performance in recognition ... is capable of a throughput of 5.000.000 fingerprints ... be ten times faster than most competitors and ...      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ) , ...
Breaking Biology News(10 mins):Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2Synaptics to Report Third Quarter Results on April 23 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3
... palm tree in Brazil, which under close examination shows ... was the top jury selection among the images captured ... example of what organizers hope participants will produce for ... GigaBlitz events are citizen science projects in which people ...
... PLoS ONE , scientists at the University of ... needed to identify the shape and texture of pollen ... vegetation. Because pollen morphologies often align quite ... pollen allows scientists to better understand prehistoric flora in ...
... are 23 Oreo-sized, cartilage-filled discs that hold the vertebrae together ... critical for movement, they can become the source of back ... problem that affects 85% of Americans and drains the U.S. ... A new biomedical device to surgically treat chronic back pain ...
Cached Biology News:Citizen scientists to document biodiversity with high-resolution imagery during summer solstice 2Evaluation of microscopy techniques may help scientists to better understand ancient plants 2BYU engineers conceive disc replacement to treat chronic low back pain 2
... T4 DNA Ligase catalyzes the formation of ... between double-stranded DNAs with 3' hydroxyl and ... Ligase buffer optimizes ligation which can be ... acids are not substrates for this enzyme. ...
Porcine Coronary Artery Smooth Muscle Cells (PCASMC) (>500,000 cells)...
Sulfadimethoxine (CH-2027)...
Bovine Pulmonary Artery Smooth Muscle Cells (BPASMC) (>500,000 cells)...
Biology Products: